NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR
INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES (OR ANY OTHER
JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE
UNLAWFUL). THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE
SECURITIES DESCRIBED HEREIN.   

The Board of Directors of Softox Solutions AS ("Softox" or the "Company") has
today resolved to call for an extraordinary general meeting in the Company on
the 31th of July 2024 to resolve, among other things, a rights issue of
approximately NOK 22,5 million (the "Rights Issue"). The summons for the
extraordinary general meeting is attached to this stock exchange notice.  

The Board of Directors has proposed the following: 
The share capital of the Company is proposed to be increased by up to NOK
24.750.165,18 through the issuance of maximum 1.237.508.259 new shares in the
Company, each with a nominal value of NOK 0,02 (the "Offer Shares").

The subscription price is proposed to be NOK 0,02 per Offer Share. The Rights
Issue will result in gross proceeds to the Company of up to NOK 24.750.165,18. 

The new shares may be subscribed for by shareholders who owned shares in the
company as of 31st July 2024 (as documented in the Norwegian Central Securities
Depository (VPS) as of 2nd August 2024) and who are not resident in a
jurisdiction where such offering would be unlawful or would (in jurisdictions
other than Norway) require any prospectus, filing, registration or similar
action (the Eligible Shareholders), and the Underwriters in accordance with the
Underwriting Agreement dated 1st of July 2024.   

Subject to the approval of the Rights Issue by the extraordinary general
meeting, Softox' shares will trade ex. subscription rights from and including
1st of August 2024 (the "Ex. Date"). 

Tradable subscription rights will be issued. The Eligible Shareholders will be
granted tradable subscription rights corresponding with their pro rata ownership
as registered in the VPS per the Record Date. The number of subscription rights
granted to each Eligible Shareholder will be rounded down to the nearest whole
subscription right. Each subscription right gives the right to subscribe for,
and be allocated, one share in the Share Issue.   

The full terms and conditions for the Rights Issue will be included in a
prospectus which will be published prior to the commencement of the subscription
period for the Rights Issue, expected to take place from 6th of August at 09:00
CEST to 23rd of August 2024 at 16:30 CEST. 

The extraordinary general meeting will be held on Wednesday 31st  July 2024 at
10:00 hours (CEST) via Electronic Meeting. 

SpareBank 1 Markets AS is acting as manager for the Rights Issue.   
Kvale Advokatfirma DA is acting as legal counsel to the Company.


For any questions or interview requests, please contact:  

Geir Almås, Chair of SoftOx Solutions AS  

Mail: ir@soft-ox.com  

Phone: Geir Almås: (+47) 977 59 071  


About SoftOx Solutions AS:
SoftOx Solutions AS (SoftOx) is a Medtech and pharmaceutical company listed on
Euronext Growth Oslo under 'SOFTX'. SoftOx Solutions AS was founded in 2012 and
is headquartered in Oslo. The SoftOx Solutions Group includes the holding
company SoftOx Solutions AS, the Malmö subsidiary Water Innovation AB, and
subsidiaries SoftOx Defense Solutions AS and SoftOx Disinfection AS. SoftOx is
developing a highly effective antimicrobial solution for use in biofilm, viral,
and antimicrobial-resistant infections. The patent-protected technology is based
on extensive research and development in partnership with leading Nordic
research institutes. 

For more information on SoftOx, visit www.soft-ox.com